Insight Molecular Diagnostics (IMDX) Change in Receivables (2020 - 2026)
Insight Molecular Diagnostics (IMDX) posted Change in Receivables of -$971000.0 for Q1 2026, down 211.61% sequentially from $870000.0 in Q4 2025, and down 150.39% YoY from $1.9 million in Q1 2025.
Insight Molecular Diagnostics (IMDX) Change in Receivables (2020 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 7 years of Change in Receivables data on file, last reported at -$971000.0 in Q1 2026.
- Quarterly Change in Receivables fell 150.39% year-over-year to -$971000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.4 million (down 200.12% YoY) and the FY2025 annual result came in at -$485000.0, down 142.96% from the prior year.
- Change in Receivables declined to -$971000.0 in Q1 2026 per IMDX's latest filing, from $870000.0 in the prior quarter.
- The five-year high for Change in Receivables was $1.9 million in Q1 2025, with the low at -$3.0 million in Q2 2025.
- Average Change in Receivables over 5 years is $8176.5, with a median of $21000.0 recorded in 2023.
- Year-over-year, Change in Receivables jumped 6585.71% in 2024 and tumbled 3884.21% in 2025.
- Insight Molecular Diagnostics' Change in Receivables stood at $22000.0 in 2022, then slipped by 4.55% to $21000.0 in 2023, then jumped by 6585.71% to $1.4 million in 2024, then sank by 38.03% to $870000.0 in 2025, then plunged by 211.61% to -$971000.0 in 2026.
- Business Quant data shows IMDX's Change in Receivables at -$971000.0 in Q1 2026, $870000.0 in Q4 2025, and -$254000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 533.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -66.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 56.81 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 121.07 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -12.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -118.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -65.11 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | -971,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -971,000.00 |
| Mar 31, 2026 | -971,000.00 |
| Dec 31, 2025 | 870,000.00 |
| Dec 31, 2025 | 870,000.00 |
| Sep 30, 2025 | -254,000.00 |
| Sep 30, 2025 | -254,000.00 |
| Jun 30, 2025 | -3.03 Mn |
| Jun 30, 2025 | -3.03 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 124,000.00 |
| Sep 30, 2024 | 124,000.00 |
| Jun 30, 2024 | -76,000.00 |
| Jun 30, 2024 | -76,000.00 |
| Mar 31, 2024 | -323,000.00 |
| Mar 31, 2024 | -323,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Dec 31, 2023 | 21,000.00 |